Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

United States

Cedars-Sinai Medical Center, Los Angeles, California

Washington University, St Louis, Missouri

France

Hôpital Necker - Enfants Malades, Paris, Paris

Germany

Universitaetsklinikum Erlangen, Erlangen, Bavaria

Universitaetsklinikum Leipzig AoeR, Leipzig, Saxony

Italy

IRCCS Ca' Granda Ospedale Policlinico, Milan

Spain

Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia

United Kingdom

University Hospital of Wales Cardiff and Vale University Local Health, Cardiff